933
Participants
Start Date
July 15, 2024
Primary Completion Date
July 1, 2026
Study Completion Date
August 1, 2026
Irinotecan Liposome
The experimental group will collect data from patients treated with Nal-IRI as the chemotherapy regimen. It is recommended to use according to the label, clinical practice shall prevail.
RECRUITING
Beijing Cancer Hospital, Beijing
Peking University
OTHER